|

HSK42360 Clinical Trials

2 actively recruiting trials

Pipeline

Phase 1: 2

Top Sponsors

  • Haisco Pharmaceutical Group Co., Ltd.2

Indications

  • Cancer2
  • Malignant Brain Tumors1
  • Solid Tumors1

Other2 trials

Phase I Study of HSK42360 in Malignant Brain Tumors With BRAF V600 Mutation
Phase 1
Phase I Study of HSK42360 in Solid Tumors With BRAF V600 Mutation
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.